Oculis Holding AG
OCSAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; no superinvestor holds it.
Other share classesOCS
Q1 2026 vs. Q4 2025
How the institutions holding Oculis Holding AG changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 10 | 8 | −2 |
| Shares | 252.4K | 220.7K | −31.7K (−12.6%) |
| Value | $2.18M | $2.91M | +$728.0K (+33.3%) |
New holders (0)
Institutions that held Oculis Holding AG at the end of Q1 2026 but not at the end of Q4 2025.
None.
Sold out (2)
Institutions that held Oculis Holding AG at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Gabelli & Co Investment Advisers, Inc. | 18,600 | $159.2K |
| Gabelli Funds LLC | 13,670 | $117.0K |